Stock Price Quote

VINEET LABORATORIES LTD.

NSE : VINEETLABBSE : 543298ISIN CODE : INE505Y01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE53.841.05 (+1.99 %)
PREV CLOSE ( ) 52.79
OPEN PRICE ( ) 53.84
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2208
TODAY'S LOW / HIGH ( )53.82 53.84
52 WK LOW / HIGH ( )45.65 88.95
NSE53.601.05 (+2 %)
PREV CLOSE( ) 52.55
OPEN PRICE ( ) 53.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 695
TODAY'S LOW / HIGH( ) 53.60 53.60
52 WK LOW / HIGH ( )44.65 88.9
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 10-11 2016
Management Info
Dilip Vishnu Acharekar - Chairman Gaddam Venkata Ramana - Managing Director
Registered Office

Address Sy.no. 11/ A3, Eshwaramma Nilayam,Saheb Nagar Kurudu V I L L,Chintalkunta, L B Nagar,
Hyderabad,
Telangana-500074

Phone 040-24128833

Email info@vineetlabs.co.in

Website www.vineetlabs.co.in

Registrars Details
Venture Capital & Corporate Investments Ltd
Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57,4th & 5th Floors,Jayabheri Enclave Phase - II, Gachibowli,Hyderabad
Listing : BSE, NSE

NEWS

02Nov Vineet Laboratories informs about boar
Vineet Laboratories has informed that a meeting of Board of Directors of..
13Oct Vineet Laboratories informs about comp
Vineet Laboratories has informed that Certificate issued by Venture Capi..
14Jun Vineet Laboratories informs about news
Pursuant to the provisions of Regulations 33 and 47 of SEBI (Listing Obl..
06Apr Vineet Laboratories informs about comp
Vineet Laboratories has informed that it enclosed the certificate issued..
20Mar Vineet Laboratories informs about disc
Vineet Laboratories has informed that the exchange has received the disc..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit-20.6512.5199999999999
Gross Profit -23.32 20.2899999999999
Operating Profit -6.2900000000000277.8199999999999
Net Sales 326.472122.93

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE)
peergroup  2621.00 (5.75%)
M.Cap ( in Cr)1619.26
Glaxosmithkline Phar (BSE)
peergroup  2079.80 (7.06%)
M.Cap ( in Cr)35233.07
TTK Healthcare (BSE)
peergroup  1591.35 (5.77%)
M.Cap ( in Cr)2248.63
Cipla (BSE)
peergroup  1398.80 (3.79%)
M.Cap ( in Cr)112938.41
Torrent Pharma (BSE)
peergroup  2685.00 (1.85%)
M.Cap ( in Cr)90872.60

Shareholding Pattern

NON-INSTITUTION 62.5%
PROMOTERS 37.5%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Vineet Laboratories Ltd.

Vineet Laboratories Ltd. was incorporated in the year 2016. Its today's share price is 53.84. Its current market capitalisation stands at Rs 49.64 Cr. In the latest quarter, company has reported Gross Sales of Rs. 2122.93 Cr and Total Income of Rs.2124.16 Cr. The company's management includes Rameshkumar Bandari, Satish Pandurang Samant, Alluri Ranga Raju, Hari Priya Yerukalapudi, Bhaskara Reddy Karna, Satyanarayana Raju Bhupathiraju, Gaddam Venkata Ramana, Dilip Vishnu Acharekar.

It is listed on the BSE with a BSE Code of 543298 , NSE with an NSE Symbol of VINEETLAB and ISIN of INE505Y01010. It's Registered office is at Sy.no. 11/ A3, Eshwaramma Nilayam,Saheb Nagar Kurudu V I L L,Chintalkunta, L B NagarHyderabad-500074, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are MM Reddy & Co, NSVR & Associates LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.